Disclosure of material issue

**NATCAPSUQ Update:** Natural Capsules (NCL) has opted *not* to subscribe to the Rights Issue offered by its subsidiary, Natural Biogenex Private Limited. **The Issue & Impact:** NCL's non-participation will lead to a 2.18% dilution of its equity stake in Natural Biogenex, reducing it from 68.96% to 66.78%. Natural Biogenex will remain an NCL subsidiary. **Company's Plan:** NCL states this decision is based on the "strategic allocation of the funds on other business matters," indicating a focus on other investment priorities. **Subsidiary Snapshot (Natural Biogenex last FY):** * Turnover: Rs 13.43 Cr * Net Worth: Rs 81.24 Cr * Profit/Loss: Rs -43.30 Cr #NATCAPSUQ #Investing #Equity